Liposome-encapsulated Irinotecan Hydrochloride PEP02 or Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil as Second-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
Clinical trial NCT01375816 · TERMINATED
Trial details
- NCT number
- NCT01375816
- Sponsor
- GERCOR - Multidisciplinary Oncology Cooperative Group
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2014-06-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.